山东大学学报 (医学版) ›› 2022, Vol. 60 ›› Issue (7): 6-19.doi: 10.6040/j.issn.1671-7554.0.2022.0356
郭孙伟1,2,刘惜时1,2
GUO Sunwei1,2, LIU Xishi1,2
摘要： 子宫腺肌病是子宫内膜腺体和间质侵入子宫肌层形成弥漫性或局限性的病变,是妇科常见多发病,被普遍认为是一个 “谜一样”的疾病,病因学及病理生理尚不明。子宫腺肌病的典型临床症状是月经量增多和进行性痛经,严重影响患者的生活质量,其治疗颇为棘手。根据10多年来的研究工作和其他发表的文献,综述子宫腺肌病的病因学、病理生理以及诊治,以期对子宫腺肌病的发病机制、病理生理研究、诊断和治疗的最新进展,以及亟待研究的今后方向,作一概括总结。
中图分类号:
| [1] Benagiano G, Brosens I. History of adenomyosis [J]. Best Pract Res Clin Obstet Gynaecol, 2006, 20(4): 449-463. [2] Munro MG. Adenomyosis: a riddle, wrapped in mystery, inside an Enigma [J]. Fertil Steril, 2021, 116(1): 89-90. [3] Farquhar C, Brosens I. Medical and surgical management of adenomyosis [J]. Best Pract Res Clin Obstet Gynaecol, 2006, 20(4): 603-616. [4] Munro MG, Critchley HOD, Fraser IS, et al. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions [J]. Int J Gynaecol Obstet, 2018, 143(3): 393-408. [5] García-Solares J, Donnez J, Donnez O, et al. Pathogenesis of uterine adenomyosis: invagination or metaplasia? [J]. Fertil Steril, 2018, 109(3): 371-379. [6] Quinn M. Uterine innervation in adenomyosis [J]. J Obstet Gynaecol, 2007, 27(3): 287-291. [7] Quinn M. Origins of western diseases [J]. J R Soc Med, 2011, 104(11): 449-456. [8] Quinn MJ. Autonomic denervation and western diseases [J]. Am J Med, 2014, 127(1): 3-4. [9] Wang X, Benagiano G, Liu XS, et al. Unveiling the pathogenesis of adenomyosis through animal models [J]. J Clin Med, 2022, 11(6): 1744. [10] Leyendecker G, Bilgicyildirim A, Inacker M, et al. Adenomyosis and endometriosis. re-visiting their association and further insights into the mechanisms of auto-traumatisation: an MRI study [J]. Arch Gynecol Obstet, 2015, 291(4): 917-932. [11] Leyendecker G, Wildt L. A new concept of endometriosis and adenomyosis: tissue injury and repair(TIAR)[J]. Horm Mol Biol Clin Investig, 2011, 5(2): 125-142. [12] Leyendecker G, Wildt L, Mall G. The pathophysiology of endometriosis and adenomyosis: tissue injury and repair [J]. Arch Gynecol Obstet, 2009, 280(4): 529-538. [13] Kissler S, Zangos S, Wiegratz I, et al. Utero-tubal sperm transport and its impairment in endometriosis and adenomyosis [J]. Ann N Y Acad Sci, 2007, 1101: 38-48. doi: 10.1196/annals.1389.036. [14] Leyendecker G, Kunz G, Wildt L, et al. Uterine hyperperistalsis and dysperistalsis as dysfunctions of the mechanism of rapid sperm transport in patients with endometriosis and infertility [J]. Hum Reprod, 1996, 11(7): 1542-1551. [15] Leyendecker G, Kunz G, Herbertz M, et al. Uterine peristaltic activity and the development of endometriosis [J]. Ann N Y Acad Sci, 2004, 1034: 338-355. doi:10.1196/annals.1335.036. [16] Leyendecker G, Kunz G, Noe M, et al. Endometriosis: a dysfunction and disease of the archimetra [J]. Hum Reprod Update, 1998, 4(5): 752-762. [17] Leyendecker G, Herbertz M, Kunz G, et al. Endometriosis results from the dislocation of basal endometrium [J]. Hum Reprod, 2002, 17(10): 2725-2736. [18] Vannuccini S, Tosti C, Carmona F, et al. Pathogenesis of adenomyosis: an update on molecular mechanisms [J]. Reprod Biomed Online, 2017, 35(5): 592-601. [19] Guo SW. The pathogenesis of adenomyosis vis-à-vis endometriosis [J]. J Clin Med, 2020, 9(2): E485. [20] Cousins FL, Dorien FO, Gargett CE. Endometrial stem/progenitor cells and their role in the pathogenesis of endometriosis [J]. Best Pract Res Clin Obstet Gynaecol, 2018, 50: 27-38. doi: 10.1016/j.bpobgyn.2018.01.011. [21] Parazzini F, Vercellini P, Panazza S, et al. Risk factors for adenomyosis [J]. Hum Reprod, 1997, 12(6): 1275-1279. [22] Taran FA, Weaver AL, Coddington CC, et al. Understanding adenomyosis: a case control study [J]. Fertil Steril, 2010, 94(4): 1223-1228. [23] Levgur M, Abadi MA, Tucker A. Adenomyosis: symptoms, histology, and pregnancy terminations [J]. Obstet Gynecol, 2000, 95(5): 688-691. [24] Templeman C, Marshall SF, Ursin G, et al. Adenomyosis and endometriosis in the California teachers study [J]. Fertil Steril, 2008, 90(2): 415-424. [25] Castelán F, López-García K, Moreno-Pérez S, et al. Multiparity affects conduction properties of pelvic floor nerves in rabbits [J]. Brain Behav, 2018, 8(10): e01105. [26] Hao MH, Liu XS, Guo SW. Adenomyosis in mice resulting from mechanically or thermally induced endometrial-myometrial interface disruption and its possible prevention [J]. Reprod Biomed Online, 2020, 41(5): 925-942. [27] Liu XS, Shen MH, Qi QM, et al. Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis [J]. Hum Reprod, 2016, 31(4): 734-749. [28] Shen MH, Liu XS, Zhang HQ, et al. Transforming growth factor β1 signaling coincides with epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis in mice [J]. Hum Reprod, 2015: dev314. doi: 10.1093/humrep/dev314. [29] Long QQ, Zheng HX, Liu XS, et al. Perioperative intervention by β-blockade and NF-κB suppression reduces the recurrence risk of endometriosis in mice due to incomplete excision [J]. Reprod Sci, 2019, 26(5): 697-708. [30] Hiraoka T, Hirota Y, Aikawa S, et al. Constant activation of STAT3 contributes to the development of adenomyosis in females [J]. Endocrinology, 2022, 163(5): bqac044. [31] Wang X, Liu X, Guo SW. Perioperative suppression of schwann cell dedifferentiation reduces the risk of adenomyosis resulting from endometrial-myometrial interface disruption in mice [J]. Biomedicines, 2022, 10: 1218. [32] Parrott E, Butterworth M, Green A, et al. Adenomyosis: a result of disordered stromal differentiation [J]. Am J Pathol, 2001, 159(2): 623-630. [33] Kishi Y, Suginami H, Kuramori R, et al. Four subtypes of adenomyosis assessed by magnetic resonance imaging and their specification [J]. Am J Obstet Gynecol, 2012, 207(2): 114. [34] Cao Y, Wang X, Liu X, et al. Neonatal feeding of an estrogen receptor β(ERβ)agonist induces external adenomyosis-like lesions in ICR mouse [J]. Reprod Dev Med, 2022. [35] Chapron C, Tosti C, Marcellin L, et al. Relationship between the magnetic resonance imaging appearance of adenomyosis and endometriosis phenotypes [J]. Hum Reprod, 2017, 32(7): 1393-1401. [36] Marcellin L, Santulli P, Bourdon M, et al. Focal adenomyosis of the outer myometrium and deep infiltrating endometriosis severity [J]. Fertil Steril, 2020, 114(4): 818-827. [37] Guo SW. Fibrogenesis resulting from cyclic bleeding: the Holy Grail of the natural history of ectopic endometrium [J]. Hum Reprod, 2018, 33(3): 353-356. [38] Huang JH, Duan H, Wang S, et al. Upregulated microRNA let-7a accelerates apoptosis and inhibits proliferation in uterine junctional zone smooth muscle cells in adenomyosis under conditions of a normal activated hippo-YAP1 axis [J]. Reproductive Biol Endocrinol, 2021, 19(1): 81. [39] Wang YY, Duan H, Wang S, et al. Talin1 induces epithelial-mesenchymal transition to facilitate endometrial cell migration and invasion in adenomyosis under the regulation of microRNA-145-5p[J]. Reproductive Sci Thousand Oaks Calif, 2021, 28(5): 1523-1539. [40] Yan DM, Liu XS, Xu H, et al. Platelets induce endothelial-mesenchymal transition and subsequent fibrogenesis in endometriosis [J]. Reprod Biomed Online, 2020, 41(3): 500-517. [41] Yan DM, Liu XS, Xu H, et al. Mesothelial cells participate in endometriosis fibrogenesis through platelet-induced mesothelial-mesenchymal transition [J]. J Clin Endocrinol Metab, 2020, 105(11): e4124-e4147. [42] Duan J, Liu XS, Wang HL, et al. The M2a macrophage subset may be critically involved in the fibrogenesis of endometriosis in mice [J]. Reprod Biomed Online, 2018, 37(3): 254-268. [43] Xiao FY, Liu XS, Guo SW. Platelets and regulatory T cells may induce a type 2 immunity that is conducive to the progression and fibrogenesis of endometriosis [J]. Front Immunol, 2020, 11: 610963. doi:10.3389/fimmu.2020.610963. [44] Barcena de Arellano ML, Arnold J, Lang H, et al. Evidence of neurotrophic events due to peritoneal endometriotic lesions [J]. Cytokine, 2013, 62(2): 253-261. [45] Barcena de Arellano ML, Arnold J, Vercellino F, et al. Overexpression of nerve growth factor in peritoneal fluid from women with endometriosis may promote neurite outgrowth in endometriotic lesions [J]. Fertil Steril, 2011, 95(3): 1123-1126. [46] Greaves E, Temp J, Esnal-Zufiurre A, et al. Estradiol is a critical mediator of macrophage-nerve cross talk in peritoneal endometriosis [J]. Am J Pathol, 2015, 185(8): 2286-2297. [47] Yan DM, Liu XS, Guo SW. Endometriosis-derived thromboxane A2 induces neurite outgrowth [J]. Reprod Sci, 2017, 24(6): 829-835. [48] Greaves E, Collins F, Esnal-Zufiaurre A, et al. Estrogen receptor(ER)agonists differentially regulate neuroangiogenesis in peritoneal endometriosis via the repellent factor SLIT3 [J]. Endocrinology, 2014, 155(10): 4015-4026. [49] Asally R, Markham R, Manconi F. The expression and cellular localisation of neurotrophin and neural guidance molecules in peritoneal ectopic lesions [J]. Mol Neurobiol, 2019, 56(6): 4013-4022. [50] Wang GY, Tokushige N, Markham R, et al. Rich innervation of deep infiltrating endometriosis [J]. Hum Reprod, 2009, 24(4): 827-834. [51] Wang GY, Tokushige N, Russell P, et al. Hyperinnervation in intestinal deep infiltrating endometriosis [J]. J Minim Invasive Gynecol, 2009, 16(6): 713-719. [52] Zhang XM, Lu BC, Huang XF, et al. Innervation of endometrium and myometrium in women with painful adenomyosis and uterine fibroids [J]. Fertil Steril, 2010, 94(2): 730-737. [53] Sun HH, Li D, Yuan M, et al. Eutopic stromal cells of endometriosis promote neuroangiogenesis via exosome pathway [J]. Biol Reprod, 2019, 100(3): 649-659. [54] Liu XS, Yan DM, Guo SW. Sensory nerve-derived neuropeptides accelerate the development and fibrogenesis of endometriosis [J]. Hum Reprod, 2019, 34(3): 452-468. [55] Yan DM, Liu XS, Guo SW. Neuropeptides substance P and calcitonin gene related peptide accelerate the development and fibrogenesis of endometriosis [J]. Sci Rep, 2019, 9(1): 2698. [56] Yan DM, Liu XS, Guo SW. Nerve fibers and endometriotic lesions: partners in crime in inflicting pains in women with endometriosis [J]. Eur J Obstet Gynecol Reprod Biol, 2017, 209: 14-24. doi: 10.1016/j.ejogrb.2016.06.017. [57] Guo SW, Zhang Q, Liu XS. Social psychogenic stress promotes the development of endometriosis in mouse [J]. Reprod Biomed Online, 2017, 34(3): 225-239. [58] Long QQ, Liu XS, Qi QM, et al. Chronic stress accelerates the development of endometriosis in mouse through adrenergic receptor β2 [J]. Hum Reprod, 2016, 31(11): 2506-2519. [59] Liu XS, Zhang Q, Guo SW. Histological and immunohistochemical characterization of the similarity and difference between ovarian endometriomas and deep infiltrating endometriosis [J]. Reprod Sci, 2018, 25(3): 329-340. [60] Nie JC, Liu XS, Guo SW. Promoter hypermethylation of progesterone receptor isoform B(PR-B)in adenomyosis and its rectification by a histone deacetylase inhibitor and a demethylation agent [J]. Reprod Sci, 2010, 17(11): 995-1005. [61] Nie J, Zhao C, Lagana AS, et al. Identification of lesional correlates with dysmenorrhea and serum anti-Mullerian hormone(AMH)levels in women with ovarian endometriomas [J]. Fert Steril, 2022. [62] Liu XS, Guo SW. Aberrant immunoreactivity of deoxyribonucleic acid methyltransferases in adenomyosis [J]. Gynecol Obstet Invest, 2012, 74(2): 100-108. [63] Liu XS, Nie JC, Guo SW. Elevated immunoreactivity against class I histone deacetylases in adenomyosis [J]. Gynecol Obstet Invest, 2012, 74(1): 50-55. [64] Guo SW. Fibrogenesis resulting from cyclic bleeding: the Holy Grail of the natural history of ectopic endometrium [J]. Hum Reprod, 2018, 33(3): 353-356. [65] As-Sanie S, Harris RE, Napadow V, et al. Changes in regional gray matter volume in women with chronic pelvic pain: a voxel-based morphometry study [J]. Pain, 2012, 153(5): 1006-1014. [66] As-Sanie S, Kim J, Schmidt-Wilcke T, et al. Functional connectivity is associated with altered brain chemistry in women with endometriosis-associated chronic pelvic pain [J]. J Pain, 2016, 17(1): 1-13. [67] Vader K, Bostick GP, Carlesso LC, et al. The revised IASP definition of pain and accompanying notes: considerations for the physiotherapy profession [J]. Physiother Can, 2021, 73: 103-106.doi: 10.3138/ptc-2020-0124-gee. [68] Nie JC, Liu XS, Guo SW. Immunoreactivity of oxytocin receptor and transient receptor potential vanilloid type 1 and its correlation with dysmenorrhea in adenomyosis [J]. Am J Obstet Gynecol, 2010, 202(4): 1-346. [69] Guo SW, Mao XY, Ma QL, et al. Dysmenorrhea and its severity are associated with increased uterine contractility and overexpression of oxytocin receptor(OTR)in women with symptomatic adenomyosis [J]. Fertil Steril, 2013, 99(1): 231-240. [70] Chen YM, Zhu B, Zhang HP, et al. Possible loss of GABAergic inhibition in mice with induced adenomyosis and treatment with epigallocatechin-3-gallate attenuates the loss with improved hyperalgesia [J]. Reprod Sci, 2014, 21(7): 869-882. [71] He WW, Liu XS, Zhang YQ, et al. Generalized hyperalgesia in women with endometriosis and its resolution following a successful surgery [J]. Reprod Sci, 2010, 17(12): 1099-1111. [72] National Institute for Health and Care Excellence. NICE guideline [NG88] : Heavy menstrual bleeding: assessment and management [J/OR].(2018)[2022-03-10]. https://www.nice.org.uk/guidance/ng88, 2018. [73] Hallberg L, Hogdahl AM, Nilsson L, et al. Menstrual blood loss-a population study. Variation at different ages and attempts to define normality [J]. Acta Obstet Gynecol Scand,1966, 45(3): 320-351. [74] Higham JM, Shaw RW. Clinical associations with objective menstrual blood volume [J]. Eur J Obstet Gynecol Reprod Biol, 1999, 82(1): 73-76. [75] Critchley HOD, Maybin JA, Armstrong GM, et al. Physiology of the endometrium and regulation of menstruation [J]. Physiol Rev, 2020, 100(3): 1149-1179. [76] Chen J, Porter AE, Kho KA. Current and future surgical and interventional management options for adenomyosis [J]. Semin Reprod Med, 2020, 38(2/3): 157-167. [77] Maybin JA, Murray AA, Saunders PTK, et al. Hypoxia and hypoxia inducible factor-1α are required for normal endometrial repair during menstruation [J]. Nat Commun, 2018, 9(1): 295. [78] Critchley HOD, Osei J, Henderson TA, et al. Hypoxia-inducible factor-1alpha expression in human endometrium and its regulation by prostaglandin E-series prostanoid receptor 2(EP2)[J]. Endocrinology, 2006, 147(2): 744-753. [79] Maybin JA, Hirani N, Jabbour HN, et al. Novel roles for hypoxia and prostaglandin E2 in the regulation of IL-8 during endometrial repair [J]. Am J Pathol, 2011, 178(3): 1245-1256. [80] Huang QQ, Liu XS, Guo SW. Higher fibrotic content of endometriotic lesions is associated with diminished prostaglandin E2 signaling [J]. Reprod Med Biol, 2021, 21(1): e12423. [81] Arosh JA, Lee J, Balasubbramanian D, et al. Molecular and preclinical basis to inhibit PGE2 receptors EP2 and EP4 as a novel nonsteroidal therapy for endometriosis [J]. Proc Natl Acad Sci USA, 2015, 112(31): 9716-9721. [82] Greaves E, Horne AW, Jerina H, et al. EP2 receptor antagonism reduces peripheral and central hyperalgesia in a preclinical mouse model of endometriosis [J]. Sci Rep, 2017, 7: 44169. doi:10.1038/srep44169. [83] Huang QQ, Liu XS, Guo SW. Changing prostaglandin E2(PGE 2)signaling during lesional progression and exacerbation of endometriosis by inhibition of PGE 2 receptor EP2 and EP4 [J]. Reprod Med Biol, 2021, 21(1): e12426. [84] Huang S, Wettlaufer SH, Hogaboam C, et al. Prostaglandin E(2)inhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling [J]. Am J Physiol Lung Cell Mol Physiol, 2007, 292(2): L405-L413. [85] Huang SK, White ES, Wettlaufer SH, et al. Prostaglandin E2induces fibroblast apoptosis by modulating multiple survival pathways [J]. FASEB J, 2009, 23(12): 4317-4326. [86] Penke LRK, Huang SK, White ES, et al. Prostaglandin E2 inhibits α-smooth muscle actin transcription during myofibroblast differentiation via distinct mechanisms of modulation of serum response factor and myocardin-related transcription factor-A [J]. J Biol Chem, 2014, 289(24): 17151-17162. [87] Wettlaufer SH, Scott JP, McEachin RC, et al. Reversal of the transcriptome by prostaglandin E2 during myofibroblast dedifferentiation [J]. Am J Respir Cell Mol Biol, 2016, 54(1): 114-127. [88] Mukherjee S, Sheng W, Michkov A, et al. Prostaglandin E 2 inhibits profibrotic function of human pulmonary fibroblasts by disrupting Ca2+ signaling [J]. Am J Physiol Lung Cell Mol Physiol, 2019, 316(5): L810-L821. [89] Matsuzaki S, Canis M, Pouly JL, et al. Cyclooxygenase-2 expression in deep endometriosis and matched eutopic endometrium [J]. Fertil Steril, 2004, 82(5): 1309-1315. [90] Buchweitz O, Staebler A, Wülfing P, et al. COX-2 overexpression in peritoneal lesions is correlated with nonmenstrual chronic pelvic pain [J]. Eur J Obstet Gynecol Reprod Biol, 2006, 124(2): 216-221. [91] Huang QQ, Liu XS, Critchley H, et al. How does the extent of fibrosis in adenomyosis lesions contribute to heavy menstrual bleeding? [J]. Reprod Med Biol, 2022, 21(1): e12442. [92] Liu XS, Ding D, Ren YY, et al. Transvaginal elastosonography as an imaging technique for diagnosing adenomyosis [J]. Reprod Sci, 2018, 25(4): 498-514. [93] Bourdon M, Oliveira J, Marcellin L, et al. Adenomyosis of the inner and outer myometrium are associated with different clinical profiles [J]. Hum Reprod, 2021, 36(2): 349-357. [94] Yamaguchi M, Yoshihara K, Suda K, et al. Three-dimensional understanding of the morphological complexity of the human uterine endometrium [J]. iScience, 2021, 24(4): 102258. [95] Tanaka M, Kyo S, Kanaya T, et al. Evidence of the monoclonal composition of human endometrial epithelial glands and mosaic pattern of clonal distribution in luminal epithelium [J]. Am J Pathol, 2003, 163(1): 295-301. [96] Wu Y, Guo SW. Reconstructing cellular lineages in endometrial cells [J]. Fertil Steril, 2008, 89(2): 481-484. [97] Bird CC, McElin TW, Manalo-Estrella P. The elusive adenomyosis of the uterus: revisited [J]. Am J Obstet Gynecol, 1972, 112(5): 583-593. [98] Tamai K, Koyama T, Umeoka S,et al. Spectrum of MR features in adenomyosis [J]. Best pract res Clin obstet gynaecol, 2006, 20(4): 583-602. [99] Dueholm M, Lundorf E, Hansen ES, et al. Magnetic resonance imaging and transvaginal ultrasonography for the diagnosis of adenomyosis [J]. Fertil Steril, 2001, 76(3): 588-594. [100] Stewart EA. Clinical practice. Uterine fibroids [J]. N Engl J Med, 2015, 372(17): 1646-1655. [101] van den Bosch T, Dueholm M, Leone FPG, et al. Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment(MUSA)group [J]. Ultrasound Obstet Gynecol, 2015, 46(3): 284-298. [102] Hall TJ. AAPM/RSNA physics tutorial for residents: topics in US: beyond the basics: elasticity imaging with US [J]. Radiographics, 2003, 23(6): 1657-1671. [103] Garra BS. Imaging and estimation of tissue elasticity by ultrasound [J]. Ultrasound Q, 2007, 23(4): 255-268. [104] Ophir J, Céspedes I, Ponnekanti H, et al. Elastography: a quantitative method for imaging the elasticity of biological tissues [J]. Ultrason Imaging, 1991, 13(2): 111-134. [105] Garra BS. Elastography: history, principles, and technique comparison [J]. Abdom Imaging, 2015, 40(4): 680-697. [106] Shiina T, Nightingale KR, Palmeri ML, et al. WFUMB guidelines and recommendations for clinical use of ultrasound elastography: part 1: basic principles and terminology [J]. Ultrasound Med Biol, 2015, 41(5): 1126-1147. [107] Shen MH, Liu XS, Zhang HQ, et al. Transforming growth factor β1 signaling coincides with epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis in mice [J]. Hum Reprod, 2015: dev314. doi: 10.1093/humrep/dev314. [108] Liu XS, Shen MH, Qi QM, et al. Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis [J]. Hum Reprod, 2016, 31(4): 734-749. [109] Liu XS, Ding D, Ren YY, et al. Transvaginal elastosonography as an imaging technique for diagnosing adenomyosis [J]. Reprod Sci, 2018, 25(4): 498-514. [110] Sharara FI, Kheil MH, Feki A, et al. Current and prospective treatment of adenomyosis [J]. J Clin Med, 2021, 10(15): 3410. [111] Osada H. Uterine adenomyosis and adenomyoma: the surgical approach [J]. Fertil Steril, 2018, 109(3): 406-417. [112] Mikos T, Lioupis M, Anthoulakis C, et al. The outcome of fertility-sparing and nonfertility-sparing surgery for the treatment of adenomyosis. A systematic review and meta-analysis [J]. J Minim Invasive Gynecol, 2020, 27(2): 309-331. [113] Ota I, Taniguchi F, Ota Y, et al. A controlled clinical trial comparing potent progestins, LNG-IUS and dienogest, for the treatment of women with adenomyosis [J]. Reprod Med Biol, 2021, 20(4): 427-434. [114] Donnez J, Donnez O, Tourniaire J, et al. Uterine adenomyosis treated by linzagolix, an oral gonadotropin-releasing hormone receptor antagonist: a pilot study with a new ‘hit hard first and then maintain’ regimen of administration [J]. J Clin Med, 2021, 10(24): 5794. [115] Donnez O, Donnez J. Gonadotropin-releasing hormone antagonist(linzagolix): a new therapy for uterine adenomyosis [J]. Fertil Steril, 2020, 114(3): 640-645. [116] Burla L, Kalaitzopoulos DR, Metzler JM, et al. Popularity of endocrine endometriosis drugs and limited alternatives in the present and foreseeable future: a survey among 1420 affected women [J]. Eur J Obstet Gynecol Reprod Biol, 2021, 262: 232-238. doi: 10.1016/j.ejogrb.2021.05.040. [117] Guo SW. An overview of the current status of clinical trials on endometriosis: issues and concerns [J]. Fertil Steril, 2014, 101(1): 183-190. [118] Guo SW, Evers JLH. Lack of transparency of clinical trials on endometriosis [J]. Obstet Gynecol, 2013, 121(6): 1281-1290. [119] Guo SW, Groothuis PG. Is it time for a paradigm shift in drug research and development in endometriosis/adenomyosis? [J]. Hum Reprod Update, 2018, 24(5): 577-598. [120] Guo SW, Hummelshoj L, Olive DL, et al. A call for more transparency of registered clinical trials on endometriosis [J]. Hum Reprod, 2009, 24(6): 1247-1254. [121] Wu Y, Guo SW. Suppression of IL-1beta-induced COX-2 expression by trichostatin a(TSA)in human endometrial stromal cells [J]. Eur J Obstet Gynecol Reprod Biol, 2007, 135(1): 88-93. [122] Wu Y, Guo SW. Inhibition of proliferation of endometrial stromal cells by trichostatin A, RU486, CDB-2914, N-acetylcysteine, and ICI 182780 [J]. Gynecol Obstet Invest, 2006, 62(4): 193-205. [123] Wu Y, Starzinski-Powitz A, Guo SW. Trichostatin A, a histone deacetylase inhibitor, attenuates invasiveness and reactivates E-cadherin expression in immortalized endometriotic cells [J]. Reprod Sci, 2007, 14(4): 374-382. [124] Liu XS, Guo SW. Valproic acid alleviates generalized hyperalgesia in mice with induced adenomyosis[J]. J Obstet Gynaecol Res, 2011, 37(7): 696-708. [125] Mao XY, Wang YD, Carter AV, et al. The retardation of myometrial infiltration, reduction of uterine contractility, and alleviation of generalized hyperalgesia in mice with induced adenomyosis by levo-tetrahydropalmatine(l-THP)and andrographolide [J]. Reprod Sci, 2011, 18(10): 1025-1037. [126] Liu XS, Guo SW. A pilot study on the off-label use of valproic acid to treat adenomyosis [J]. Fertil Steril, 2008, 89(1): 246-250. [127] Liu XS, Yuan L, Guo SW. Valproic acid as a therapy for adenomyosis: a comparative case series[J]. Reprod Sci, 2010, 17(10): 904-912. [128] Costalonga EC, de Freitas LJ, Aragone DDSP, et al. Anti-fibrotic effects of valproic acid in experimental peritoneal fibrosis [J]. PLoS One, 2017, 12(9): e0184302. doi: 10.1371/journal.pone.0184302. [129] Larsson P, Alwis I, Niego B, et al. Valproic acid selectively increases vascular endothelial tissue-type plasminogen activator production and reduces Thrombus formation in the mouse [J]. J Thromb Haemost, 2016, 14(12): 2496-2508. [130] Zhu B, Chen YM, Shen XL, et al. Anti-platelet therapy holds promises in treating adenomyosis: experimental evidence [J]. Reprod Biol Endocrinol, 2016, 14(1): 66. [131] Li B, Chen M, Liu XS, et al. Constitutive and tumor necrosis factor-α-induced activation of nuclear factor-κB in adenomyosis and its inhibition by andrographolide [J]. Fertil Steril, 2013, 100(2): 568-577. [132] Liu XS, Yu S, Guo SW. A pilot study on the use of andrographolide to treat symptomatic adenomyosis[J]. Gynecol Minim Invasive Ther, 2014, 3(4): 119-126. [133] Ding D, Cai XJ, Zheng HX, et al. Scutellarin suppresses platelet aggregation and stalls lesional progression in mouse with induced endometriosis [J]. Reprod Sci, 2019, 26(11): 1417-1428. [134] Guo SW, Du YB, Liu XS. Platelet-derived TGF-β1 mediates the down-modulation of NKG2D expression and may be responsible for impaired natural killer(NK)cytotoxicity in women with endometriosis [J]. Hum Reprod, 2016, 31(7): 1462-1474. [135] Luo M, Cai XJ, Yan DM, et al. Sodium tanshinone IIA sulfonate restrains fibrogenesis through induction of senescence in mice with induced deep endometriosis [J]. Reprod Biomed Online, 2020, 41(3): 373-384. [136] Zhu B, Chen YM, Zhang HP, et al. Resveratrol reduces myometrial infiltration, uterine hyperactivity, and stress levels and alleviates generalized hyperalgesia in mice with induced adenomyosis [J]. Reprod Sci, 2015, 22(11): 1336-1349. [137] Nie JC, Liu XS. Quercetin alleviates generalized hyperalgesia in mice with induced adenomyosis [J]. Mol Med Rep, 2017, 16(4): 5370-5376. [138] Nie JC, Liu XS. Leonurine attenuates hyperalgesia in mice with induced adenomyosis [J]. Med Sci Monit, 2017, 23: 1701-1706. doi:10.12659/msm.900233. [139] Nie J, Yang HM, Sun CY, et al. Scutellarin enhances antitumor effects and attenuates the toxicity of bleomycin in H22 ascites tumor-bearing mice [J]. Front Pharmacol, 2018, 9: 615. doi:10.3389/fphar.2018.00615. [140] Huang SH, Xiao FY, Guo SW, et al. Tetramethylpyrazine retards the progression and fibrogenesis of endometriosis [J]. Reprod Sci, 2022, 29(4): 1170-1187. [141] Madueke-Laveaux OS, Elsharoud A, Al-Hendy A. What we know about the long-term risks of hysterectomy for benign indication-A systematic review [J]. J Clin Med, 2021, 10(22): 5335. |
| [1] | 王国云,潘臧钰. 子宫腺肌病动物模型研究进展[J]. 山东大学学报 (医学版), 2022, 60(7): 48-55. |
| [2] | 颜磊,陈子江. 子宫腺肌病合并不孕的治疗[J]. 山东大学学报 (医学版), 2022, 60(7): 43-47. |
| [3] | 陶国伟,王芳,董向毅,徐亚瑄,赵琳丽,胡蓓蓓. 子宫腺肌病的超声与MRI诊断及进展[J]. 山东大学学报 (医学版), 2022, 60(7): 56-65. |
| [4] | 艾星子·艾里,郭铮宇,张晓霏. 子宫腺肌病高强度聚焦超声消融治疗研究进展[J]. 山东大学学报 (医学版), 2022, 60(7): 36-42. |
| [5] | 易晓芳,黄季华. 子宫腺肌病的患者教育及全程管理[J]. 山东大学学报 (医学版), 2022, 60(7): 32-35. |
| [6] | 张信美,徐萍. 子宫腺肌病的手术治疗策略[J]. 山东大学学报 (医学版), 2022, 60(7): 26-31. |
| [7] | 冷金花, 史精华. 子宫腺肌病的临床表现[J]. 山东大学学报 (医学版), 2022, 60(7): 1-5. |
| [8] | 彭超,周应芳. 子宫腺肌病的药物治疗进展[J]. 山东大学学报 (医学版), 2022, 60(7): 20-25. |
| [9] | 徐歌,李青,张灿灿,田永杰. 子宫腺肌病组织及原代细胞中PARP-1、HIF-1α的表达及临床意义[J]. 山东大学学报 (医学版), 2022, 60(4): 55-61. |
| [10] | 罗湘杭,周若玙. 骨质疏松的病因及发病机制研究进展[J]. 山东大学学报 (医学版), 2021, 59(6): 10-14. |
| [11] | 耿晨,杨阳,赵月,刘浩冉,晁岚. 子宫腺肌病中差异基因筛选及Wilms tumor-1的表达[J]. 山东大学学报 (医学版), 2021, 59(4): 79-86. |
| [12] | 杨贵霞,徐阳,马明明,宋然,朱鹏飞. 宫腹腔镜联合治疗Robert子宫合并子宫腺肌病1例[J]. 山东大学学报 (医学版), 2021, 59(1): 122-124. |
| [13] | 王冰玉,杨阳,晁岚. TOLL样受体4在15例子宫腺肌病中的表达及作用[J]. 山东大学学报 (医学版), 2020, 58(6): 47-52. |
| [14] | 江志伟,王刚. 延迟性术后肠麻痹的概念及防治策略[J]. 山东大学学报 (医学版), 2020, 58(5): 1-5. |
| [15] | 周道斌,张炎. 原发性中枢神经系统淋巴瘤诊治现状及进展[J]. 山东大学学报 (医学版), 2019, 57(7): 31-39. |
|
